The Discovery and Development of AZD1402/PRS-060, an Inhaled, Potent and Selective Antagonist of the IL-4 Receptor Alpha

G. Matschiner (Boston, United States of America), S. Huang (Geneva, Switzerland), S. Constant (Geneva, Switzerland), B. Rattenstetter (Boston, United States of America), H. Gille (Niederzier, Germany), A. Hohlbaum (Ghent, Belgium), B. Koller (Chapell Hill, United States of America), D. Keeling (Gothenburg, Sweden), M. Fitzgerald (Boston, United States of America)

Source: International Congress 2018 – Basic pharmacology
Session: Basic pharmacology
Session type: Thematic Poster
Number: 1047
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Matschiner (Boston, United States of America), S. Huang (Geneva, Switzerland), S. Constant (Geneva, Switzerland), B. Rattenstetter (Boston, United States of America), H. Gille (Niederzier, Germany), A. Hohlbaum (Ghent, Belgium), B. Koller (Chapell Hill, United States of America), D. Keeling (Gothenburg, Sweden), M. Fitzgerald (Boston, United States of America). The Discovery and Development of AZD1402/PRS-060, an Inhaled, Potent and Selective Antagonist of the IL-4 Receptor Alpha. 1047

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: